APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Pharmaceuticals and Supplements

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Selected research

Industry Growth & Trends

Global Equine Pharmaceuticals and Supplements Industry Growth and Trends Forecast to 2032

21 December 2025101 pages

Choose your research edition.

Industry ResearchEquine Pharmaceuticals and Supplements Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Pharmaceuticals and Supplements Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Equine Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Pharmaceuticals and Supplements Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Pharmaceuticals and Supplements Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.

North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.

Read the full market overview

In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.

Report Scope

This report provides a structured, data-driven view of the global Equine Pharmaceuticals and Supplements market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Equine Pharmaceuticals and Supplements market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Equine Pharmaceuticals and Supplements market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Equine Pharmaceuticals and Supplements.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Equine Pharmaceuticals and Supplements market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Equine Pharmaceuticals and Supplements Market by Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Equine Pharmaceuticals and Supplements Segment by Type

Pharmaceuticals

Supplements

Equine Pharmaceuticals and Supplements Segment by Application

Thoroughbred Horse

Other Types of Horses

Equine Pharmaceuticals and Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Pharmaceuticals and Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Equine Pharmaceuticals and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pharmaceuticals Table 2. Major Company of Supplements Table 3. Global Equine Pharmaceuticals and Supplements Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 5. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type (2021-2026) Table 6. Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (US$ Million) Table 7. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type (2021-2026) Table 8. Global Equine Pharmaceuticals and Supplements Price by Type (2021-2026) & (USD/Unit) Table 9. Global Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 10. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type (2027-2032) Table 11. Global Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (US$ Million) Table 12. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type (2027-2032) Table 13. Global Equine Pharmaceuticals and Supplements Price by Type (2027-2032) & (USD/Unit) Table 14. North America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 15. North America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 17. Europe Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 21. Latin America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (US$ Million) Table 24. Equine Pharmaceuticals and Supplements Industry Trends Table 25. Equine Pharmaceuticals and Supplements Industry Drivers Table 26. Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges Table 27. Equine Pharmaceuticals and Supplements Industry Restraints Table 28. Global Equine Pharmaceuticals and Supplements Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2021-2026) Table 30. Global Equine Pharmaceuticals and Supplements Sales by Company (2021-2026) & (K Units) Table 31. Global Equine Pharmaceuticals and Supplements Sales Share by Company (2021-2026) Table 32. Global Equine Pharmaceuticals and Supplements Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Equine Pharmaceuticals and Supplements Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Equine Pharmaceuticals and Supplements Major Company Production Sites and Headquarters Table 35. Global Equine Pharmaceuticals and Supplements Company, Product Type & Application Table 36. Global Equine Pharmaceuticals and Supplements Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Equine Pharmaceuticals and Supplements Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units) Table 41. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Region (2021-2026) Table 42. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (US$ Million) Table 43. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Region (2021-2026) Table 44. Global Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Equine Pharmaceuticals and Supplements Sales by Region (2027-2032) & (K Units) Table 46. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Region (2027-2032) Table 47. Global Equine Pharmaceuticals and Supplements Sales by Region (2027-2032) & (US$ Million) Table 48. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Region (2027-2032) Table 49. Global Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Equine Pharmaceuticals and Supplements Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 52. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application (2021-2026) Table 53. Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (US$ Million) Table 54. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application (2021-2026) Table 55. Global Equine Pharmaceuticals and Supplements Price by Application (2021-2026) & (USD/Unit) Table 56. Global Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 57. Global Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application (2027-2032) Table 58. Global Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (US$ Million) Table 59. Global Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application (2027-2032) Table 60. Global Equine Pharmaceuticals and Supplements Price by Application (2027-2032) & (USD/Unit) Table 61. North America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 62. North America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 64. Europe Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 68. Latin America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Merck Animal Health Company Information Table 77. Merck Animal Health Business Overview Table 78. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 80. Merck Animal Health Recent Development Table 81. Zoetis Company Information Table 82. Zoetis Business Overview Table 83. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Zoetis Equine Pharmaceuticals and Supplements Product Portfolio Table 85. Zoetis Recent Development Table 86. Bayer Animal Health Company Information Table 87. Bayer Animal Health Business Overview Table 88. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 90. Bayer Animal Health Recent Development Table 91. Elanco Animal Health Company Information Table 92. Elanco Animal Health Business Overview Table 93. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 95. Elanco Animal Health Recent Development Table 96. Dechra Veterinary Products Company Information Table 97. Dechra Veterinary Products Business Overview Table 98. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio Table 100. Dechra Veterinary Products Recent Development Table 101. CEVA Company Information Table 102. CEVA Business Overview Table 103. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. CEVA Equine Pharmaceuticals and Supplements Product Portfolio Table 105. CEVA Recent Development Table 106. Virbac Company Information Table 107. Virbac Business Overview Table 108. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Virbac Equine Pharmaceuticals and Supplements Product Portfolio Table 110. Virbac Recent Development Table 111. Norbrook Equine Company Information Table 112. Norbrook Equine Business Overview Table 113. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio Table 115. Norbrook Equine Recent Development Table 116. Kyoritsu Seiyaku Company Information Table 117. Kyoritsu Seiyaku Business Overview Table 118. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio Table 120. Kyoritsu Seiyaku Recent Development Table 121. Vetoquinol Company Information Table 122. Vetoquinol Business Overview Table 123. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio Table 125. Vetoquinol Recent Development Table 126. Protexin Healthcare Company Information Table 127. Protexin Healthcare Business Overview Table 128. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio Table 130. Protexin Healthcare Recent Development Table 131. Audevard Company Information Table 132. Audevard Business Overview Table 133. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Audevard Equine Pharmaceuticals and Supplements Product Portfolio Table 135. Audevard Recent Development Table 136. Ouro Fino Saude Company Information Table 137. Ouro Fino Saude Business Overview Table 138. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio Table 140. Ouro Fino Saude Recent Development Table 141. North America Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 143. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2026) Table 144. North America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Country (2027-2032) Table 146. North America Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Equine Pharmaceuticals and Supplements Market Share by Country (2021-2026) Table 149. North America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Equine Pharmaceuticals and Supplements Market Share Forecast by Country (2027-2032) Table 151. Europe Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 153. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2026) Table 154. Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Equine Pharmaceuticals and Supplements Market Share by Country (2021-2026) Table 159. Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Equine Pharmaceuticals and Supplements Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Equine Pharmaceuticals and Supplements Market Share by Country (2021-2026) Table 169. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Equine Pharmaceuticals and Supplements Market Share Forecast by Country (2027-2032) Table 171. Latin America Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 173. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2026) Table 174. Latin America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Equine Pharmaceuticals and Supplements Market Share by Country (2021-2026) Table 179. Latin America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Equine Pharmaceuticals and Supplements Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Equine Pharmaceuticals and Supplements Market Share by Country (2021-2026) Table 189. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Equine Pharmaceuticals and Supplements Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Equine Pharmaceuticals and Supplements Distributors List Table 194. Equine Pharmaceuticals and Supplements Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Equine Pharmaceuticals and Supplements Image Figure 2. Global Equine Pharmaceuticals and Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Pharmaceuticals and Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Pharmaceuticals and Supplements Sales (2021-2032) & (K Units) Figure 5. Pharmaceuticals Image Figure 6. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (K Units) Figure 7. Supplements Image Figure 8. Global Supplements Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Equine Pharmaceuticals and Supplements Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Equine Pharmaceuticals and Supplements Market Share by Type 2025 VS 2032 Figure 11. North America Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type in 2025 Figure 12. North America Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type in 2025 Figure 13. Europe Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type in 2025 Figure 14. Europe Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type in 2025 Figure 17. Latin America Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Equine Pharmaceuticals and Supplements Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Thoroughbred Horse Image Figure 24. Global Thoroughbred Horse Sales YoY Growth (2021-2032) & (K Units) Figure 25. Other Types of Horses Image Figure 26. Global Other Types of Horses Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Equine Pharmaceuticals and Supplements Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Equine Pharmaceuticals and Supplements Market Share by Application 2025 VS 2032 Figure 29. North America Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application in 2025 Figure 30. North America Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application in 2025 Figure 31. Europe Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application in 2025 Figure 32. Europe Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application in 2025 Figure 35. Latin America Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share in Value by Application in 2025 Figure 39. North America Equine Pharmaceuticals and Supplements Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Equine Pharmaceuticals and Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Equine Pharmaceuticals and Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Equine Pharmaceuticals and Supplements Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Equine Pharmaceuticals and Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Equine Pharmaceuticals and Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Equine Pharmaceuticals and Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Equine Pharmaceuticals and Supplements Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Equine Pharmaceuticals and Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Equine Pharmaceuticals and Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Equine Pharmaceuticals and Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Equine Pharmaceuticals and Supplements Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Equine Pharmaceuticals and Supplements Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Supplements
Applications
  • Thoroughbred Horse
  • Other Types of Horses
Companies covered
  • Boehringer Ingelheim
  • Merck Animal Health
  • Zoetis
  • Bayer Animal Health
  • Elanco Animal Health
  • Dechra Veterinary Products
  • CEVA
  • Virbac
  • Norbrook Equine
  • Kyoritsu Seiyaku
  • Vetoquinol
  • Protexin Healthcare
  • Audevard
  • Ouro Fino Saude

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Equine Pharmaceuticals and Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Equine Pharmaceuticals and Supplements Market by Type
  6. 1.3.1 Pharmaceuticals
  7. 1.3.2 Supplements
  8. 1.4 Global Equine Pharmaceuticals and Supplements Market Size by Type
  9. 1.4.1 Global Equine Pharmaceuticals and Supplements Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Equine Pharmaceuticals and Supplements Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Equine Pharmaceuticals and Supplements Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Equine Pharmaceuticals and Supplements Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Equine Pharmaceuticals and Supplements Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Equine Pharmaceuticals and Supplements Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Equine Pharmaceuticals and Supplements Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Equine Pharmaceuticals and Supplements Industry Trends
  2. 2.2 Equine Pharmaceuticals and Supplements Industry Drivers
  3. 2.3 Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges
  4. 2.4 Equine Pharmaceuticals and Supplements Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Equine Pharmaceuticals and Supplements Revenue (2021-2026)
  2. 3.2 Global Top Players by Equine Pharmaceuticals and Supplements Sales (2021-2026)
  3. 3.3 Global Top Players by Equine Pharmaceuticals and Supplements Price (2021-2026)
  4. 3.4 Global Equine Pharmaceuticals and Supplements Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Equine Pharmaceuticals and Supplements Major Company Production Sites & Headquarters
  6. 3.6 Global Equine Pharmaceuticals and Supplements Company, Product Type & Application
  7. 3.7 Global Equine Pharmaceuticals and Supplements Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Equine Pharmaceuticals and Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Equine Pharmaceuticals and Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Equine Pharmaceuticals and Supplements Tier 1, Tier 2, and Tier 3
4 Equine Pharmaceuticals and Supplements Regional Status and Outlook
  1. 4.1 Global Equine Pharmaceuticals and Supplements Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Equine Pharmaceuticals and Supplements Historic Market Size by Region
  3. 4.2.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Equine Pharmaceuticals and Supplements Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Equine Pharmaceuticals and Supplements Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Equine Pharmaceuticals and Supplements Forecasted Market Size by Region
  7. 4.3.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Equine Pharmaceuticals and Supplements Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Equine Pharmaceuticals and Supplements Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Equine Pharmaceuticals and Supplements by Application
  1. 5.1 Equine Pharmaceuticals and Supplements Market by Application
  2. 5.1.1 Thoroughbred Horse
  3. 5.1.2 Other Types of Horses
  4. 5.2 Global Equine Pharmaceuticals and Supplements Market Size by Application
  5. 5.2.1 Global Equine Pharmaceuticals and Supplements Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Equine Pharmaceuticals and Supplements Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Equine Pharmaceuticals and Supplements Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Equine Pharmaceuticals and Supplements Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Equine Pharmaceuticals and Supplements Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Equine Pharmaceuticals and Supplements Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Equine Pharmaceuticals and Supplements Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Merck Animal Health
  8. 6.2.1 Merck Animal Health Company Information
  9. 6.2.2 Merck Animal Health Business Overview
  10. 6.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  12. 6.2.5 Merck Animal Health Recent Developments
  13. 6.3 Zoetis
  14. 6.3.1 Zoetis Company Information
  15. 6.3.2 Zoetis Business Overview
  16. 6.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
  18. 6.3.5 Zoetis Recent Developments
  19. 6.4 Bayer Animal Health
  20. 6.4.1 Bayer Animal Health Company Information
  21. 6.4.2 Bayer Animal Health Business Overview
  22. 6.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  24. 6.4.5 Bayer Animal Health Recent Developments
  25. 6.5 Elanco Animal Health
  26. 6.5.1 Elanco Animal Health Company Information
  27. 6.5.2 Elanco Animal Health Business Overview
  28. 6.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  30. 6.5.5 Elanco Animal Health Recent Developments
  31. 6.6 Dechra Veterinary Products
  32. 6.6.1 Dechra Veterinary Products Company Information
  33. 6.6.2 Dechra Veterinary Products Business Overview
  34. 6.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
  36. 6.6.5 Dechra Veterinary Products Recent Developments
  37. 6.7 CEVA
  38. 6.7.1 CEVA Company Information
  39. 6.7.2 CEVA Business Overview
  40. 6.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
  42. 6.7.5 CEVA Recent Developments
  43. 6.8 Virbac
  44. 6.8.1 Virbac Company Information
  45. 6.8.2 Virbac Business Overview
  46. 6.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
  48. 6.8.5 Virbac Recent Developments
  49. 6.9 Norbrook Equine
  50. 6.9.1 Norbrook Equine Company Information
  51. 6.9.2 Norbrook Equine Business Overview
  52. 6.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
  54. 6.9.5 Norbrook Equine Recent Developments
  55. 6.10 Kyoritsu Seiyaku
  56. 6.10.1 Kyoritsu Seiyaku Company Information
  57. 6.10.2 Kyoritsu Seiyaku Business Overview
  58. 6.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
  60. 6.10.5 Kyoritsu Seiyaku Recent Developments
  61. 6.11 Vetoquinol
  62. 6.11.1 Vetoquinol Company Information
  63. 6.11.2 Vetoquinol Business Overview
  64. 6.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
  66. 6.11.5 Vetoquinol Recent Developments
  67. 6.12 Protexin Healthcare
  68. 6.12.1 Protexin Healthcare Company Information
  69. 6.12.2 Protexin Healthcare Business Overview
  70. 6.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
  72. 6.12.5 Protexin Healthcare Recent Developments
  73. 6.13 Audevard
  74. 6.13.1 Audevard Company Information
  75. 6.13.2 Audevard Business Overview
  76. 6.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
  78. 6.13.5 Audevard Recent Developments
  79. 6.14 Ouro Fino Saude
  80. 6.14.1 Ouro Fino Saude Company Information
  81. 6.14.2 Ouro Fino Saude Business Overview
  82. 6.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
  84. 6.14.5 Ouro Fino Saude Recent Developments
7 North America by Country
  1. 7.1 North America Equine Pharmaceuticals and Supplements Sales by Country
  2. 7.1.1 North America Equine Pharmaceuticals and Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026)
  4. 7.1.3 North America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032)
  5. 7.2 North America Equine Pharmaceuticals and Supplements Market Size by Country
  6. 7.2.1 North America Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026)
  8. 7.2.3 North America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
  2. 8.1.1 Europe Equine Pharmaceuticals and Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026)
  4. 8.1.3 Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Equine Pharmaceuticals and Supplements Market Size by Country
  6. 8.2.1 Europe Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026)
  8. 8.2.3 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Country
  2. 9.1.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Country
  6. 9.2.1 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Equine Pharmaceuticals and Supplements Sales by Country
  2. 10.1.1 South America Equine Pharmaceuticals and Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026)
  4. 10.1.3 South America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032)
  5. 10.2 South America Equine Pharmaceuticals and Supplements Market Size by Country
  6. 10.2.1 South America Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026)
  8. 10.2.3 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country
  2. 11.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Equine Pharmaceuticals and Supplements Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country
  6. 11.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
  2. 12.1.1 Equine Pharmaceuticals and Supplements Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Equine Pharmaceuticals and Supplements Production Mode & Process
  7. 12.2 Equine Pharmaceuticals and Supplements Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Equine Pharmaceuticals and Supplements Distributors
  10. 12.2.3 Equine Pharmaceuticals and Supplements Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst